Judgment of the General Court of 15 September 2017 — Viridis Pharmaceutical v EUIPO — Hecht-Pharma (Boswelan)
(Case T-276/16) 1
(EU trade mark — Revocation proceedings — EU word mark Boswelan — Declaration of revocation –Article 51(1)(a) of Regulation (EC) No 207/2009 –No genuine use of the trade mark — No proper reasons for non-use)
Language of the case: German
Parties
Applicant: Viridis Pharmaceutical Ltd (Tortola, British Virgin Isles) (represented by: C. Spintig, S. Pietzcker and M. Prasse, lawyers)
Defendant: European Union Intellectual Property Office (represented by: S. Hanne, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Hecht-Pharma GmbH (Hollnseth, Germany) (represented by: C. Sachs and J. Sachs, lawyers)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 29 February 2016 (Case R 2837/2014-5), relating to revocation proceedings between Hecht-Pharma and Viridis Pharmaceutical.
Operative part of the judgment
The Court:
1. Dismisses the action;
2. Orders Viridis Pharmaceutical Ltd to pay the costs.
____________
1 OJ C 251, 11.7.2016.